Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Grisold

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
European Journal of Neurology|August 20, 2010
Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task ForceR Soffietti, B G Baumert, L Bello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiformeM J van den Bent, W Grisold, D Frappaz, et al.
Journal of Neuro-Oncology|July 21, 2014
End of life care in high-grade glioma patients in three European countries: a comparative studyJ A F Koekkoek, L Dirven, J C Reijneveld, et al.
European Journal of Neurology|February 5, 2016
Endovascular stroke therapy in Austria: a nationwide 1-year experienceW Serles, T Gattringer, S Mutzenbach, et al.
British Journal of Cancer|November 21, 2013
Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour RegistryA Woehrer, M Hackl, T Waldhör, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsG Cavaletti, D R Cornblath, I S J Merkies, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
European Journal of Neurology|August 20, 2010
Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task ForceR Soffietti, B G Baumert, L Bello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiformeM J van den Bent, W Grisold, D Frappaz, et al.
Journal of Neuro-Oncology|July 21, 2014
End of life care in high-grade glioma patients in three European countries: a comparative studyJ A F Koekkoek, L Dirven, J C Reijneveld, et al.
European Journal of Neurology|February 5, 2016
Endovascular stroke therapy in Austria: a nationwide 1-year experienceW Serles, T Gattringer, S Mutzenbach, et al.
British Journal of Cancer|November 21, 2013
Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour RegistryA Woehrer, M Hackl, T Waldhör, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsG Cavaletti, D R Cornblath, I S J Merkies, et al.
Pageof 15